drugset / Trial / NCT01364376

S-1 Plus Oxaliplatin Compared With Fluorouracil, Leucovorin Calcium Plus Oxaliplatin as Perioperative Chemotherapy for Advanced Gastric Carcinoma

NCT01364376

Completed 583 enrolled Zhejiang University
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a randomized multicenter controlled study of oxaliplatin, leucovorin calcium , plus 5-fluorouracil (FOLFOX) compared with S-1 plus oxaliplatin (SOX) as perioperative chemotherapy for advanced gastric cancer. Hypothesis: SOX is not inferior to FOLFOX as perioperative chemotherapy for advanced gastric cancer.

Timeline

Start
2011-06
Primary completion
2016-08
Completion
2016-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Leucovorin Small molecule 400 mg/m2
Subject Oxaliplatin Small molecule 130 mg/m2
Subject S-1 Small molecule 80 mg Oral
Subject S-1 Small molecule 120 mg Oral
Subject fluorouracil Small molecule 400 mg/m2 Intravenous
Subject fluorouracil Small molecule 2400 mg/m2 Intravenous

Indications